Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.58 |
| ▸ | CA2 | P00918 | 2/20 | 0.58 |
| ▸ | CA7 | P43166 | 2/20 | 0.58 |
| ▸ | CA9 | Q16790 | 2/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL871495 | 0.91 | ACP3 (0.56) | CA1CA2CA7CA9CA12 | |
| SCHEMBL15087401 | 0.89 | CA1 (0.46) | CA1CA2CA7CA9CA12 | |
| SCHEMBL9425364 | 0.84 | CA1 (0.58) | CA1CA2CA7CA9CA12 | |
| SCHEMBL677832 | 0.82 | CA1 (0.55) | CA1CA2CA7CA9CA12 | |
| SCHEMBL11442189 | 0.81 | APP (0.55) | TDP1ALDH1A1MAPK1L3MBTL1CYP1A2 | |
| SCHEMBL28083383 | 0.80 | ALDH1A1 (0.54) | CA1CA2CA7CA9CA12 | |
| SCHEMBL1295194 | 0.80 | CA1 (0.52) | CA1CA2CA7CA9CA12 | |
| SCHEMBL27668587 | 0.80 | CA1 (0.52) | CA1CA2CA7CA9CA12 | |
| SCHEMBL7188669 | 0.79 | CA1 (0.58) | CA1CA2CA7CA9CA12 | |
| SCHEMBL19077747 | 0.78 | CA1 (0.65) | CA1CA2CA7CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4691558-A2 | TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS | University Court of The University of Dundee (GB) | 2026-02-11 | — | — | EP | disclosed |
| US-20250295789-A1 | TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS | UNIVERSITY COURT OF THE UNIVERSITY OF DUNDEE (GB) | 2025-09-25 | — | — | US | disclosed |
| EP-2857018-B1 | Treatment or prophylaxis of proliferative conditions | UNIV COURT OF THE UNIV OF DUNDEE (GB) | 2025-09-03 | — | — | EP | disclosed |
| US-20220031852-A1 | TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS | UNIVERSITY COURT OF THE UNIVERSITY OF DUNDEE (GB) | 2022-02-03 | — | — | US | disclosed |
| US-20200360521-A1 | TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS | UNIVERSITY COURT OF THE UNIVERSITY OF DUNDEE (GB) | 2020-11-19 | — | — | US | disclosed |
| US-9919060-B2 | Treatment or prophylaxis of proliferative conditions | UNIVERSITY COURT OF THE UNIVERSITY OF DUNDEE (GB) | 2018-03-20 | — | — | US | disclosed |
| US-20170368188-A1 | TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS | UNIVERSITY COURT OF THE UNIVERSITY OF DUNDEE (GB) | 2017-12-28 | — | — | US | disclosed |
| EP-2857018-A1 | Treatment or prophylaxis of proliferative conditions | University Court of The University of Dundee (GB) | 2015-04-08 | — | — | EP | disclosed |
| US-20150011512-A1 | TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS | UNIVERSITY COURT OF THE UNIVERSITY OF DUNDEE (GB) | 2015-01-08 | — | — | US | disclosed |
| US-20120302748-A1 | TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS | THE UNIVERSITY COURT OF THE UNIVERSITY OF DUNDEE (GB) | 2012-11-29 | — | — | US | disclosed |
| US-5578415-A | THIN FILM WITH LUSTER LAYER COMPRISING HYDROPHOBIC BINDER, METALLIC PARTICLES AND A TRANSPARENT PROTECTIVE FILM; LASER RECORDING, READING | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1996-11-26 | — | — | US | disclosed |
| EP-0361204-B1 | Optical recording materials, method for preparing the same and optical cards having the same | ASAHI CHEMICAL IND (JP) | 1994-11-30 | — | — | EP | disclosed |
| EP-0361204-A2 | Optical recording materials, method for preparing the same and optical cards having the same | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1990-04-04 | — | — | EP | disclosed |
| US-4335957-A | Image forming method and apparatus therefor | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1982-06-22 | — | — | US | disclosed |
| US-4327176-A | IMPACT RESISTANT ACRYLIC ESTER RESIN BINDER | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1982-04-27 | — | — | US | disclosed |
| US-4325629-A | Image forming method and apparatus therefor | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1982-04-20 | — | — | US | disclosed |
| US-4287295-A | Image forming method and apparatus therefor | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1981-09-01 | — | — | US | disclosed |
| US-4268626-A | Dry image forming material | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1981-05-19 | — | — | US | disclosed |
| US-4227799-A | Image forming apparatus | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1980-10-14 | — | — | US | disclosed |
| US-4188226-A | OXIDIZER, REDUCER, HALOGENATED CARBOCYCLIC COMPOUND | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1980-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200360521-A1 | TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS | CYP1B1, UGT1A1, CYP1A1 | CA1 3263/4885CA2 2188/4885CA7 2835/4885 |
| US-20120302748-A1 | TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS | BRCA1, CYP1B1, UGT1A1 | CA1 4007/4885CA2 3157/4885CA7 3203/4885 |
| US-20220031852-A1 | TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS | CYP1B1, UGT1A1, CYP1A1 | CA1 3263/4885CA2 2188/4885CA7 2835/4885 |
| US-20250295789-A1 | TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS | CYP1B1, BRCA1, UGT1A1 | CA1 3527/4885CA2 2213/4885CA7 2831/4885 |
| US-20170368188-A1 | TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS | CYP1B1, UGT1A1, CYP1A1 | CA1 3344/4885CA2 2402/4885CA7 2285/4885 |
| US-20150011512-A1 | TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS | CYP1B1, UGT1A1, CYP1A1 | CA1 3263/4885CA2 2188/4885CA7 2835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.